November 30, 2015
Recommended Topic Related To:


"June 10, 2015 -- A new class of medications can lower "bad" LDL cholesterol to unheard-of levels, and it may be on the horizon.

The new class is called PCSK9 inhibitors. An FDA advisory panel on Tuesday recommended that the agency approve t"...




There is no specific treatment in the event of overdose of JUXTAPID. In the event of overdose, the patient should be treated symptomatically and supportive measures instituted as required. Liver-related tests should be monitored. Hemodialysis is unlikely to be beneficial given that lomitapide is highly protein bound.


JUXTAPID is contraindicated in the following conditions:

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 5/14/2015


Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Cholesterol Management

Tips to keep it under control.